Interview with Dr. Jeffrey Hebert, Associate Professor, Physical Medicine & Rehabilitation-Physical Therapy Program RMMSC: Could you please give us a brief overview of the PCORI study on MS and exercise? Dr….
Read More
By Becky Post, Certified Therapeutic Recreation Specialist, Adventure Recreation Coordinator at RMMSC’s King Adult Day Enrichment Program The RMMSC’s King Adult Day Enrichment Program (KADEP) offers several outing opportunities for…
This week, the results from a clinical trial of 250 participants with progressive MS were released and showed that ibudilast on had a significant impact in slowing down brain volume…
This past month, the MSYPN met with RMMSC Board Chair, Del Arnold, and Board Member, Erica Tarpey. Del and Erica discussed their careers, what led them to the RMMSC board, and…
An Interview with Dr. Roger Enoka with the Neurophysiology of Movement Laboratory at University of Colorado Boulder campus Dr. Roger Enoka, a professor at the University of Colorado Boulder, has…
Quite a bit’s going on in the world of disease modifying therapies (DMTs), and we’ve prepared a brief update for you. Read on for more about Gilenya’s FDA approval for…
The Spring 2018 issue of InforMS magazine focuses on leisure: an often misunderstood and under-appreciated component of health and wellbeing. In this issue of eMS News, we’d like to tell…
Results from a study led by Dr. Jeffrey Hebert, PT, PhD of the University of Colorado School of Medicine at the Anschutz Medical Campus were published last month in the…
By Amanda L. Piquet, MD | Autoimmune Neurology is a rapidly evolving field in Neurology. Autoimmune diseases that target the central nervous system involve a variety of diseases that are…
Our understanding about the connection between diet and MS is an evolving body of research. A recent study published in the journal of Neurology this month adds to our overall…